Influence of nitric oxide-donating nonsteroidal anti-inflammatory drugs on the evolution of acute pancreatitis

Shock

Volumn 25, Issue 2, 2006, Pages 190-203

  Cosen Binker, Laura Iris ^a,b,c   Binker, Marcelo Gustavo ^a,b,d   Cosen, Rodica ^b   Negri, Gustavo ^a   Tiscornia, Osvaldo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b RHC LICB Medical Research Institute Buenos Aires   (Argentina)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Acute pancreatitis; NO donors; NO flurbiprofen; NO NSAIDs; NSAIDs

Indexed keywords

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFUSIONS, PARENTERAL; MALE; MICROCIRCULATION; NITRIC OXIDE DONORS; PANCREATIC DUCTS; PANCREATITIS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33646801253     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000192122.91166.a8     Document Type: Article

References (57)

1. Banks P: Acute pancreatitis: clinical presentation. In: Go V, Gardener J, Brooks F, Lebenthal E, Di Magno E, Scheele G: The Exocrine Pancreas: Biology, Pathohiology and Disease. 2nd ed. New York: Raven Press, 1993, 475-480.
2. Ishimaru K, Mitsuoka H, Unno N, Inuzuka K, Nakamura S, Schmid-Schonbein GW: Pancreatic proteases and inflammatory mediators in peritoneal fluid during splanchnic arterial occlusion and reperfusion. Shock 22:467-471, 2004.
3. Cosen-Binker LI, Binker MG, Negri G, Tiscornia O: Acute pancreatitis: possible initial triggering mechanism and prophylaxis. Pancreatology 3:445-456, 2003.
4. Cosen-Binker LI, Binker MG, Negri G, Tiscornia O: Influence of stress in acute pancreatitis and correlation with stress-induced gastric ulcer. Pancreatology 4:470-484, 2004.
5. Tiscornia O, Celener D, Vaccaro MI, Cresta D, Waisman H: Biliary acute pancreatitis: role of autonomous nervous system and disruption of entero-pancreatic-feedback. Pren Med Arg 85:494-503, 1988.
6. Leindler L, Morschl E, Laszlo E, Mandi Y, Takacs T, Jarmai K, Farkas G: Importance of cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing pancreatitis in rats. Pancreas 29:157-161, 2004.
7. Harbrecht B, Perpetua M, Fulmer M, Zhang B: Glucagon regulates hepatic inducible nitric oxide synthesis in vivo. Shock 22:157-162, 2004.
8. Liaw W, Chen T, Lai Z, Chen S, Chen A, Tzao C, Wu J, Wu C: Effects of a membrane-permeable radical scavenger, Temopl, on intraperitoneal sepsis-induced organ injury in rats. Shock 23:88-96, 2005.
9. Werner J, Rivera J, Fernandez del Castillo C, Lewandrowski K, Adrie C, Rattner D, Warshaw AL: Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery 121:23-30, 1997.
10. DiMagno M, Williams JA, Hao Y, Ernst SA, Owyang C: Endothelial nitric oxide synthase is protective in the initiation of caerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol 287:G80-G87, 2004.
11. Wallace JL, del Soldato P: The therapeutic potential of NO-NSAIDs. Fundam Clin Pharmacol 17:11-20, 2003.
12. Lanas A, Bajador E, Serrano P, Fuentes J, Carreno S, Guardia J, Sanz M, Montoro M, Sainz R: Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 343:834-839, 2000.
13. Wallace JL: Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112:1000-1016, 1997.
14. Wallace JL, Muscara MN, McKnight W, Dicay M, del Soldato P, Cirino G: In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016. Thromb Res 93:43-50, 1999.
15. Wenk GL, Rosi S, McGann K, Hauss-Wegrzyniak B: A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. Eur J Pharmacol 453:319-324, 2002.
16. Lee PC, Salyapongse AN, Bragdon GA, Shears LL, Watkins SC, Edington HDJ, Billiar TR: Impaired wound healing and angiogenesis in e-NOS-deficient mice. Am J Physiol Heart Circ Physiol 277:H1600-H1608, 1999.
17. Ziehe M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036-2044, 1994.
18. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chenn DH, Chen DF, Symes JH, et al: Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567-2578, 1998.
19. Marshall M, Moore PK: Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood. Eur J Pharmacol 483:317-322, 2004.
20. Stamler JS, Lamas S, Fang FC: Nitrosylation, the prototypic redox-based signaling mechanism. Cell 106:675-683, 2001.
21. Reed JC: Apoptosis-based therapies. Nat Rev Drug Discov 1:111-121, 2002.
22. Dinarello CA, Margolis NH: Stopping the cuts: the recently discovered enzymes that process the precursors of inflammatory cytokines are good targets for the design of new anti-inflammatory therapeutic agents. Curr Biol 5:587-590, 1995.
23. del Soldato P, Sorrentino R, Pinto A: NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol Sci 20:319-323, 1999.
24. Keeble J, Moore P: Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol 137:295-310, 2002.
25. Whittle BJR: Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol 17:301-313, 2003.
26. Turesin F, del Soldato P, Wallace J: Enhanced anti-inflammatory potency of a nitric oxide-releasing prednisolone derivative in the rat. Br J Pharmacol 139:966-972, 2003.
27. Wallace JL, Ignarro LJ, Fiorucci S: Potential cardioprotective actions of NO-releasing aspirin. Nat Rev Drug Discov 1:375-382, 2002.
28. Carini M, Aldini G, Stefani R, Orioli M, Facino RM: Nitrosylhemoglobin, an unequivocal index of nitric oxide release from nitroaspirin: in vitro and in vivo studies in the rat by ESR spectroscopy. J Pharm Biomed Anal 26:509-518, 2001.
29. Al-Swayeh OA, Clifford RH, del Soldato P, Moore PK: A comparison of the anti-inflammatory and anti- nocieptive activity of nitroaspirin and aspirin. Br J Pharmacol 129:343-350, 2000.
30. Ermak T, Grendell J, Brandoug L: Anatomy, embryology and developmental anomalies. In: Slessinger M, Fordtram J: Gastrointestinal Disease. 3rd ed. Philadelphia, Pa: W.B. Saunders Co., 1983, 1415-1425.
31. Lowry O, Rosebrough N, Farr A, Randall R: Protein measurement with the phenol reagent. J Biol Chem 193:265-275, 1951.
32. Trush M, Egner P, Kensler T: Myeloperoxidase as a biomarker of skin irritation and inflammation. Food Chem Toxicol 32:143-147, 1994.
33. Negri G, Cosen-Binker LI, Bustos D: Myeloperoxidase (MPO) activity: a correlation with the inflammation degree in an experimental model of acute pancreatitis in the rat. Clin Chem Lab Med 39(special suppl. S):248, 2001.
34. Winer B, Brown D, Michels K: Statistical Principles in Experimental Design. New York: McGraw-Hill Book Co., 1991.
35. Al-Mufti R, Williamson R, Mathie R: Increased nitric oxide activity in a rat model of acute pancreatitis. Gut 43:564-570, 1998.
36. Wallace JL, Elliott SN, del Soldato P, McKnight W, Sannicolo F, Cirino G: Gastrointestinal-sparing anti-inflammatory drugs: the development of nitric oxide-releasing NSAIDs. Drug Dev Res 42:144-149, 1997.
37. Serhan CN, Oliw E: Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 107:1481-1489, 2001.
38. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol 231:232-235, 1971.
39. Awtry EH, Loscalzo J: Aspirin. Circulation 101:1206-1218, 2000.
40. Vane J: Towards a better aspirin. Nature 367:215-216, 1994.
41. Yin MJ, Yamamoto Y, Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκBkinase-β. Nature 396:77-80, 1998.
42. Fiorucci S, Santucci L, Cirino G, Mencarelli A, Familiari L, del Soldato P, Morelli A: IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide- releasing nonsteroidal anti-inflammatory drugs. J Immunol 165:5245-5254, 2000.
43. Fiorucci S, Mencarelli A: Palazzetti B, del Soldato P, Morelli A, Ignaro LJ: An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci USA. 2652-2657, 2001.
44. Katsuyama K, Shichiri M, Marumo F, Hirata Y: NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α. J Immunol 15:2889-2895, 1998.
45. Parks JH, Chang SH, Lee KM, Shin SH: Protective effect of nitric oxide in an endotoxin-induced septic shock. Am J Surg 171:340-346, 1996.
46. Radomski MW, Moncada S: The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol 344:164-251, 1993.
47. Gaboury J, Woodman RC, Granger DN, Kubes P: Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 265:H862-H867, 1993.
48. Wallace JL, McKnight W, Wilson TL, del Soldato P, Cirino G: Reduction of shock-induced gastric damage by nitric oxide-releasing aspirin derivative: role of neutrophils. Am J Physiol Gastrointest Liver Physiol 273:G1246-G1251, 1997.
49. Muscara MN, Lovren F, McKnight W, Dicay M, del Soldato P, Triggle CR, Wallace JL: Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats. Br J Pharmacol 133:1314-1322, 2001.
50. Momi S, Emerson M, Paul W, Leone M, Mezzasoma AM, del Soldato P, Page CP, Gresele P: Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. Eur J Pharmacol 397:177-185, 2001.
51. Wainwright CL, Miller AM, Work LM, del Soldato P: NCX 4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. Br J Pharmacol 135:1882-1888, 2002.
52. Shizukuda Y, Tang S, Yokota R, Ware JA: Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cδ activity. Circ Res 85:247-256, 1999.
53. Nishino T, Watanabe S, Oyama H: Fukuya Y, Hayashi N, Kobayashi M: An endothelial nitric oxide synthase inhibitor aggravates CDL-induced acute pancreatitis in rats. Pancreas 19:390-400, 1999.
54. Molero X, Guarner F, Salas A, Mourelle M, Puig V, Malagelada JR: Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: effects in acute pancreatitis. Gastroenterology 108:1855-1862, 1995.
55. Liu X, Nakano I, Yamaguchi H, Ito T, Goto M, Koyanagi S, Kinjoh M, Nawata H: Protective effect of nitric oxide on development of acute pancreatitis in rats. Dig Dis Sci 40:2162-2169, 1995.
56. Werner J, Fernandez del Castillo C, Rivera JA, Kollias N, Lewandrowski KB, Rattner DW, Warshaw AL: On the protective mechanisms of nitric oxide in acute pancreatitis. Gut 43:401-407, 1998.
57. Huang J, Moochhala SM, Moore PK, Bhatia M: Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury. Shock 24:182-187, 2005.